Rica Bhattacharyya and Vikas Dandekar

(The Economic Times)

1 story

Bayer Targets GLP-1 Side Effect Solutions for India
Bayer plans to launch products addressing GLP-1 drug side effects in India by 2030.
The Economic Times · 1m